Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Data Device Corporation (DDC) introduces CCGA Rad-Hard DDR2 SDRAM for space applications June 21, 2019 DARPA Awards Raytheon a $63.3 Million Contract for Hypersonic Weapons Research March 12, 2019 Seeq announces applications as SaaS Offering on Microsoft Azure September 26, 2018
Data Device Corporation (DDC) introduces CCGA Rad-Hard DDR2 SDRAM for space applications June 21, 2019